% | $
Quotes you view appear here for quick access.

Celldex Therapeutics, Inc. Message Board

  • weightbayou weightbayou Nov 24, 2013 3:59 PM Flag

    $100 within 2 years. CLDX is like SGEN and Alexion combined.

    Today's news is fantastic! When cdx-110 gets approved, off label use for cancers such as head and neck could bring in big revenues.

    Any week now phase 3 for cdx-011 will start. However, Celldex's biggest blockbusters will likely be the synergistic drugs shown below.

    Celldex has three drugs that can be used for combination therapies. CDX-301, CDX-1127, and CDX-1401. CDX-1401 is already in a combination trial. ARIA is having a great day because of a positive EU opinion. However, the stock is down big from its 52 high because its blood cancer drug has bad side effects. What if its dose could be lowered if it was used in conjunction with CDX-1401? Think about that. The potential combinations of using CDX-301, CDX-1127, or CDX-1401 with other drugs would possibly be in the hundreds. Other companies would pay for such trials in some cases.

    Sentiment: Strong Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
3.50-0.28(-7.41%)Aug 24 4:00 PMEDT